人工心臓(VAD)の世界市場:医療機器パイプライン分析2016

GlobalDataが発行した調査報告書(GDME0295EPD)
◆英語タイトル:Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0295EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年12月1日
◆ページ数:218
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016
Summary

GlobalData’s Medical Devices sector report, “Ventricular Assist Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Ventricular Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ventricular Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ventricular Assist Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ventricular Assist Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ventricular Assist Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 15
2 Introduction 16
2.1 Ventricular Assist Devices Overview 16
3 Products under Development 17
3.1 Ventricular Assist Devices – Pipeline Products by Stage of Development 17
3.2 Ventricular Assist Devices – Pipeline Products by Segment 18
3.3 Ventricular Assist Devices – Pipeline Products by Territory 19
3.4 Ventricular Assist Devices – Pipeline Products by Regulatory Path 20
3.5 Ventricular Assist Devices – Pipeline Products by Estimated Approval Date 21
3.6 Ventricular Assist Devices – Ongoing Clinical Trials 22
4 Ventricular Assist Devices – Pipeline Products under Development by Companies 23
4.1 Ventricular Assist Devices Companies – Pipeline Products by Stage of Development 23
4.2 Ventricular Assist Devices – Pipeline Products by Stage of Development 26
5 Ventricular Assist Devices Companies and Product Overview 30
5.1 Abiomed, Inc. Company Overview 30
5.1.1 Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.2 Biophan Technologies, Inc. Company Overview 41
5.2.1 Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.3 BioVentrix Inc Company Overview 42
5.3.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.4 Braile Biomedica Ltda Company Overview 45
5.4.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 45
5.5 Calon Cardio-Technology Ltd Company Overview 46
5.5.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.6 CardiacAssist Inc Company Overview 49
5.6.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.7 CARDIAnove Company Overview 50
5.7.1 CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 50
5.8 Cardio Vox, Inc. Company Overview 51
5.8.1 Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.9 CardioKinetix Inc Company Overview 52
5.9.1 CardioKinetix Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.10 CardioPlus, Inc. Company Overview 55
5.10.1 CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.11 Carnegie Mellon University Company Overview 56
5.11.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 56
5.12 Cleveland Clinic Hospital Company Overview 57
5.12.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 57
5.13 Cleveland Heart Inc Company Overview 58
5.13.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 58
5.14 CorAssist Cardiovascular Ltd Company Overview 59
5.14.1 CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
5.15 Corinnova Inc Company Overview 62
5.15.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.16 CorWave Company Overview 66
5.16.1 CorWave Pipeline Products & Ongoing Clinical Trials Overview 66
5.17 Drexel University Company Overview 68
5.17.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 DUALIS MedTech GmbH Company Overview 69
5.18.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Duke University Company Overview 70
5.19.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Ension, Inc. Company Overview 71
5.20.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.21 Evaheart Inc Company Overview 72
5.21.1 Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 72
5.22 Everheart Systems, LLC Company Overview 74
5.22.1 Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 74
5.23 FineHeart Company Overview 75
5.23.1 FineHeart Pipeline Products & Ongoing Clinical Trials Overview 75
5.24 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 76
5.24.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 76
5.25 Gold Medical Technologies, Inc. Company Overview 77
5.25.1 Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.26 HeartWare International Inc Company Overview 78
5.26.1 HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 78
5.27 Indiana University Company Overview 90
5.27.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview 90
5.28 Jarvik Heart Inc Company Overview 91
5.28.1 Jarvik Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 91
5.29 LaunchPoint Technologies, Inc. Company Overview 97
5.29.1 LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 Leviticus Cardio Ltd Company Overview 99
5.30.1 Leviticus Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
5.31 Levram Medical Systems Ltd Company Overview 101
5.31.1 Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Lonestar Heart Inc Company Overview 102
5.32.1 Lonestar Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 Mayo Clinic US Company Overview 104
5.33.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 104
5.34 Medtronic plc Company Overview 106
5.34.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 106
5.35 Micro Interventional Devices, Inc. Company Overview 108
5.35.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 108
5.36 MyoCardioCare, Inc. Company Overview 109
5.36.1 MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.37 NeoCardial Technologies, LLC Company Overview 112
5.37.1 NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.38 Nipro Corp Company Overview 113
5.38.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 113
5.39 NuPulse Inc Company Overview 114
5.39.1 NuPulse Inc Pipeline Products & Ongoing Clinical Trials Overview 114
5.40 Penn State Milton S Hershey Medical Center Company Overview 115
5.40.1 Penn State Milton S Hershey Medical Center Pipeline Products & Ongoing Clinical Trials Overview 115
5.41 PlugMed Heart SAS Company Overview 117
5.41.1 PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview 117
5.42 Procyrion Company Overview 118
5.42.1 Procyrion Pipeline Products & Ongoing Clinical Trials Overview 118
5.43 Purdue University Company Overview 119
5.43.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 119
5.44 QRS Diagnostic LLC Company Overview 121
5.44.1 QRS Diagnostic LLC Pipeline Products & Ongoing Clinical Trials Overview 121
5.45 ReliantHeart, Inc. Company Overview 122
5.45.1 ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.46 Rutgers The State University of New Jersey Company Overview 128
5.46.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 128
5.47 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 130
5.47.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 130
5.48 St. Jude Medical Inc Company Overview 131
5.48.1 St. Jude Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 131
5.49 Sunshine Heart Company, Pty. Ltd. Company Overview 134
5.49.1 Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 SynCardia Systems, Inc. Company Overview 139
5.50.1 SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 139
5.51 Teleflex Inc Company Overview 142
5.51.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 142
5.52 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 144
5.52.1 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview 144
5.53 The Pennsylvania State University Company Overview 145
5.53.1 The Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 145
5.54 Thoratec Corp Company Overview 146
5.54.1 Thoratec Corp Pipeline Products & Ongoing Clinical Trials Overview 146
5.55 Tokyo Medical and Dental University Company Overview 156
5.55.1 Tokyo Medical and Dental University Pipeline Products & Ongoing Clinical Trials Overview 156
5.56 U.S. Stem Cell Inc Company Overview 157
5.56.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 157
5.57 University of Louisville Company Overview 159
5.57.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 159
5.58 University of Michigan Company Overview 160
5.58.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 160
5.59 University of Minnesota Company Overview 161
5.59.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 161
5.60 University of Zurich Company Overview 162
5.60.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 162
5.61 Vadovations, Inc. Company Overview 163
5.61.1 Vadovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 163
5.62 Vienna University of Technology Company Overview 164
5.62.1 Vienna University of Technology Pipeline Products & Ongoing Clinical Trials Overview 164
5.63 Windmill Cardiovascular Systems, Inc. Company Overview 165
5.63.1 Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 165
5.64 Yale University Company Overview 166
5.64.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 166
6 Ventricular Assist Devices- Recent Developments 168
6.1 Nov 30, 2016: Getinge Group’s Intra-Aortic Balloon Counterpulsation Technology Validated as First-Line Mechanical Circulatory Support Device 168
6.2 Nov 29, 2016: Medtronic First to Receive European Approval for Less-Invasive HVAD Implant Procedure 168
6.3 Nov 16, 2016: St. Jude Medical HeartMate 3 LVAS Demonstrated Improved Clinical Outcomes for Patients Suffering from Advanced Heart Failure 169
6.4 Nov 09, 2016: Arrhythmia Research Technology Reports 2016 Third Quarter Results 170
6.5 Nov 04, 2016: Corwave Raises USD17.2 Million in Series B Financing 172
6.6 Oct 31, 2016: Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients 172
6.7 Oct 28, 2016: HeartWare Recalls Ventricular Assist Device Controllers 173
6.8 Oct 27, 2016: Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study 173
6.9 Oct 27, 2016: Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year 175
6.10 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 175
6.11 Oct 27, 2016: Amedisys Previews Third Quarter 2016 Results 178
6.12 Oct 21, 2016: Jarvik Heart Receives FDA Approval for Clinical Trial of Miniature Heart Assist Device for Infants and Children 178
6.13 Oct 21, 2016: HeartWare Recalls Ventricular Assist Device Pumps Due to Contamination Causing Electrical Issues 179
6.14 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 180
6.15 Oct 04, 2016: Steven Healy appointed as Chairman of the Board of Directors of BioVentrix 181
6.16 Sep 30, 2016: FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls 182
6.17 Sep 27, 2016: Abiomed Impella 5.0 Heart Pump Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare 183
6.18 Sep 27, 2016: Abiomed Impella 2.5 Heart Pump Receive Regulatory Approval From Japan MHLW 184
6.19 Sep 08, 2016: CARMAT: 2016 half-year results in line with the progress achieved by the Company 185
6.20 Sep 01, 2016: Hazard alert: HeartWare Ventricular Assist Device 186
6.21 Sep 01, 2016: CARMAT announces the departure of Marcello Conviti, CEO 186
6.22 Sep 01, 2016: Stephane Piat, Previously Division Vice President of Abbott in California, Has Been Appointed CEO of CARMAT 186
6.23 Aug 11, 2016: Arrhythmia Research Technology Reports 2016 Second Quarter Results 187
6.24 Aug 11, 2016: Abiomed Outlines Long-Term Growth Strategy and Unveils Future Products at Annual Investor Conference 189
6.25 Aug 03, 2016: U.S. Stem Cell Reports Positive Results for Q2 2016 190
6.26 Aug 02, 2016: ReliantHeart’s aVAD Gets CE Mark 190
6.27 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 191
6.28 Jul 28, 2016: HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue 192
6.29 Jul 28, 2016: Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year 194
6.30 Jul 25, 2016: LaunchPoint Announces New Analytics Executive 195
6.31 Jul 21, 2016: CardioKinetix Announces the 500th Parachute Heart Failure Device Implantation 195
6.32 Jul 21, 2016: BioVentrix Raises USD1.2 Million in Venture Financing 196
6.33 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 196
6.34 Jul 02, 2016: Versa Capital Management Acquires SynCardia Systems 198
6.35 Jun 27, 2016: Medtronic Acquires HeartWare International for USD1.1 Billion 198
6.36 Jun 20, 2016: St. Jude Medical HeartMate 3 Left Ventricular Assist System Wins CARDIOSTIM-EHRA EUROPACE Innovation Award 198
6.37 May 24, 2016: Sunshine Heart Announces OPTIONS HF Clinical Experience 199
6.38 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 200
6.39 May 05, 2016: U.S. Stem Cell Reports Positive Results for Q1 2016 200
6.40 May 04, 2016: HeartWare International Reports First Quarter 2016 Financial Results 201
6.41 May 03, 2016: Abiomed Announces Q4 FY 2016 Revenue of $94.0 Million, Up 39% Over Prior Year 202
6.42 Apr 28, 2016: Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients 203
6.43 Apr 28, 2016: HeartMate 3 CE Mark Trial 1-Year Results Presented at ISHLT 36th Annual Meeting and Scientific Sessions in Washington, D.C. 204
6.44 Apr 27, 2016: HeartWare Completes Enrollment In HVAD System LATERAL Study 204
6.45 Apr 20, 2016: HeartWare Announces HVAD System Scientific Presentations At The International Society For Heart And Lung Transplantation 36th Annual Meeting 205
6.46 Apr 07, 2016: Abiomed Impella Therapy Receives FDA Approval for Cardiogenic Shock After Heart Attack or Heart Surgery 207
7 Appendix 215
7.1 Methodology 215
7.2 About GlobalData 218
7.3 Contact Us 218
7.4 Disclaimer 218

1.1 List of Tables
Table 1: Ventricular Assist Devices - Pipeline Products by Stage of Development 17
Table 2: Ventricular Assist Devices - Pipeline Products by Segment 18
Table 3: Ventricular Assist Devices - Pipeline Products by Territory 19
Table 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path 20
Table 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date 21
Table 6: Ventricular Assist Devices - Ongoing Clinical Trials 22
Table 7: Ventricular Assist Devices Companies - Pipeline Products by Stage of Development 23
Table 8: Ventricular Assist Devices - Pipeline Products by Stage of Development 26
Table 9: Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 10: Impella 2.5 - Cardiogenic Shock - Product Status 31
Table 11: Impella 2.5 - Cardiogenic Shock - Product Description 31
Table 12: Impella 2.5 System - Product Status 31
Table 13: Impella 2.5 System - Product Description 32
Table 14: Impella 5.0 - Cardiogenic Shock - Product Status 32
Table 15: Impella 5.0 - Cardiogenic Shock - Product Description 33
Table 16: Impella 5.5 - Product Status 33
Table 17: Impella 5.5 - Product Description 33
Table 18: Impella BTR - Product Status 34
Table 19: Impella BTR - Product Description 34
Table 20: Impella CP - Product Status 34
Table 21: Impella CP - Product Description 35
Table 22: Impella CP - Cardiogenic Shock - Product Status 35
Table 23: Impella CP - Cardiogenic Shock - Product Description 36
Table 24: Impella ECP - Product Status 36
Table 25: Impella ECP - Product Description 36
Table 26: Impella RP - Product Status 37
Table 27: Impella RP - Product Description 37
Table 28: Next Generation Impella CP - STEMI - Product Status 37
Table 29: Next Generation Impella CP - STEMI - Product Description 38
Table 30: Abiomed, Inc. - Ongoing Clinical Trials Overview 38
Table 31: Impella RP - The Use of Impella RP Support System in Patients With Right Heart Failure: A Clinical and Probable Benefit Study 39
Table 32: Impella CP - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial 39
Table 33: Next Generation Impella CP - STEMI - Door to Unloading (DTU) with Impella CP System in Acute Myocardial Infarction to Reduce Infarct Size 40
Table 34: Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 35: Myotech Circulatory Support System - Product Status 41
Table 36: Myotech Circulatory Support System - Product Description 41
Table 37: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 38: Next Generation Revivent-TC System - Product Status 42
Table 39: Next Generation Revivent-TC System - Product Description 42
Table 40: PliCath HF - Product Status 43
Table 41: PliCath HF - Product Description 43
Table 42: BioVentrix Inc - Ongoing Clinical Trials Overview 44
Table 43: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 44
Table 44: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 45
Table 45: Blood Pump - Product Status 45
Table 46: Blood Pump - Product Description 45
Table 47: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
Table 48: BridgeVAD - Product Status 46
Table 49: BridgeVAD - Product Description 46
Table 50: Calon MiniVAD - Product Status 47
Table 51: Calon MiniVAD - Product Description 47
Table 52: CathVAD - Product Status 48
Table 53: CathVAD - Product Description 48
Table 54: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 55: Pediatric pVAD - Product Status 49
Table 56: Pediatric pVAD - Product Description 49
Table 57: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 50
Table 58: CARDIAnove Pump - Product Status 50
Table 59: CARDIAnove Pump - Product Description 50
Table 60: Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
Table 61: Transcatheter Ventricular Assist Device - Product Status 51
Table 62: Transcatheter Ventricular Assist Device - Product Description 51
Table 63: CardioKinetix Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 64: Parachute Ventricular Partitioning Device - Product Status 52
Table 65: Parachute Ventricular Partitioning Device - Product Description 52
Table 66: CardioKinetix Inc - Ongoing Clinical Trials Overview 53
Table 67: Parachute Ventricular Partitioning Device - A Dual-Arm, Open-Label, Multi-Center Registry Designed To Evaluate The Parachute Implant in Ischemic Heart Failure Patients 54
Table 68: Parachute Ventricular Partitioning Device - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease 54
Table 69: Parachute Ventricular Partitioning Device - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease. A German Trial to Evaluate the Improvement in Quality of Life and Cardiac Output Following Implanting of the Parachute Implant System : PARACHUTE V 54
Table 70: CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 71: CardioPlus - Product Status 55
Table 72: CardioPlus - Product Description 55
Table 73: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 56
Table 74: tVAD - Heart Failure - Product Status 56
Table 75: tVAD - Heart Failure - Product Description 56
Table 76: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 57
Table 77: PediPump - Product Status 57
Table 78: PediPump - Product Description 57
Table 79: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 80: SmartHeart LVAD - Product Status 58
Table 81: SmartHeart LVAD - Product Description 58
Table 82: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 83: CORolla - Product Status 59
Table 84: CORolla - Product Description 59
Table 85: ImCardia - Product Status 60
Table 86: ImCardia - Product Description 60
Table 87: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview 60
Table 88: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction 61
Table 89: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility 61
Table 90: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 91: CardiacSTAR - Bridge To Decision - Product Status 62
Table 92: CardiacSTAR - Bridge To Decision - Product Description 62
Table 93: CardiacSTAR - Bridge To Recovery - Product Status 63
Table 94: CardiacSTAR - Bridge To Recovery - Product Description 63
Table 95: CardiacSTAR - Bridge To Transplant - Product Status 64
Table 96: CardiacSTAR - Bridge To Transplant - Product Description 64
Table 97: CardiacSTAR - Destination Therapy - Product Status 65
Table 98: CardiacSTAR - Destination Therapy - Product Description 65
Table 99: CardiacSTAR - Heart Rehabilitation - Product Status 65
Table 100: CardiacSTAR - Heart Rehabilitation - Product Description 66
Table 101: CorWave Pipeline Products & Ongoing Clinical Trials Overview 66
Table 102: Left Ventricular Assist Device - Product Status 66
Table 103: Left Ventricular Assist Device - Product Description 67
Table 104: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 68
Table 105: Intravascular Blood Pump - Product Status 68
Table 106: Intravascular Blood Pump - Product Description 68
Table 107: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 69
Table 108: CAREFLOW Pump - Product Status 69
Table 109: CAREFLOW Pump - Product Description 69
Table 110: Duke University Pipeline Products & Ongoing Clinical Trials Overview 70
Table 111: Para-Aortic Blood Pump - Product Status 70
Table 112: Para-Aortic Blood Pump - Product Description 70
Table 113: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 114: CardioFlowPQ - Product Status 71
Table 115: CardioFlowPQ - Product Description 71
Table 116: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 72
Table 117: EVAHEART Left Ventricular Assist System - Product Status 72
Table 118: EVAHEART Left Ventricular Assist System - Product Description 73
Table 119: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 74
Table 120: Fully Implantable Left Ventricular Assist Device - Product Status 74
Table 121: Fully Implantable Left Ventricular Assist Device - Product Description 74
Table 122: FineHeart Pipeline Products & Ongoing Clinical Trials Overview 75
Table 123: ICOMS - Product Status 75
Table 124: ICOMS - Product Description 75
Table 125: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 76
Table 126: Ventricular Assist Device - Product Status 76
Table 127: Ventricular Assist Device - Product Description 76
Table 128: Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 129: Magnevad III - Product Status 77
Table 130: Magnevad III - Product Description 77
Table 131: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 132: BiVAD - Product Status 79
Table 133: BiVAD - Product Description 79
Table 134: Fully Implantable VAD System - Product Status 79
Table 135: Fully Implantable VAD System - Product Description 80
Table 136: HeartWare IV-VAD - Product Status 80
Table 137: HeartWare IV-VAD - Product Description 80
Table 138: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Status 81
Table 139: HeartWare Ventricular Assist Device - Bridge-To-Transplant - Product Description 81
Table 140: HeartWare Ventricular Assist Device - Destination Therapy - Product Status 82
Table 141: HeartWare Ventricular Assist Device - Destination Therapy - Product Description 82
Table 142: Levacor Rotary VAD - Product Status 83
Table 143: Levacor Rotary VAD - Product Description 83
Table 144: Longhorn - Product Status 83
Table 145: Longhorn - Product Description 84
Table 146: MiFlow VAD - Product Status 84
Table 147: MiFlow VAD - Product Description 84
Table 148: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Status 85
Table 149: Miniaturized Ventricular Assist Device (MVAD) Pump - Product Description 85
Table 150: VCAN Trans-Mitral - Product Status 85
Table 151: VCAN Trans-Mitral - Product Description 86
Table 152: HeartWare International Inc - Ongoing Clinical Trials Overview 86

1.2 List of Figures
Figure 1: Ventricular Assist Devices - Pipeline Products by Stage of Development 17
Figure 2: Ventricular Assist Devices - Pipeline Products by Segment 18
Figure 3: Ventricular Assist Devices - Pipeline Products by Territory 19
Figure 4: Ventricular Assist Devices - Pipeline Products by Regulatory Path 20
Figure 5: Ventricular Assist Devices - Pipeline Products by Estimated Approval Date 21
Figure 6: Ventricular Assist Devices - Ongoing Clinical Trials 22

【掲載企業】

Abiomed, Inc.
Biophan Technologies, Inc.
BioVentrix Inc
Braile Biomedica Ltda
Calon Cardio-Technology Ltd
CardiacAssist Inc
CARDIAnove
Cardio Vox, Inc.
CardioKinetix Inc
CardioPlus, Inc.
Carnegie Mellon University
Cleveland Clinic Hospital
Cleveland Heart Inc
CorAssist Cardiovascular Ltd
Corinnova Inc
CorWave
Drexel University
DUALIS MedTech GmbH
Duke University
Ension, Inc.
Evaheart Inc
Everheart Systems, LLC
FineHeart
Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
Gold Medical Technologies, Inc.
HeartWare International Inc
Indiana University
Jarvik Heart Inc
LaunchPoint Technologies, Inc.
Leviticus Cardio Ltd
Levram Medical Systems Ltd
Lonestar Heart Inc
Mayo Clinic US
Medtronic plc
Micro Interventional Devices, Inc.
MyoCardioCare, Inc.
NeoCardial Technologies, LLC
Nipro Corp
NuPulse Inc
Penn State Milton S Hershey Medical Center
PlugMed Heart SAS
Procyrion
Purdue University
QRS Diagnostic LLC
ReliantHeart, Inc.
Rutgers The State University of New Jersey
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical Inc
Sunshine Heart Company, Pty. Ltd.
SynCardia Systems, Inc.
Teleflex Inc
The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development
The Pennsylvania State University
Thoratec Corp
Tokyo Medical and Dental University
U.S. Stem Cell Inc
University of Louisville
University of Michigan
University of Minnesota
University of Zurich
Vadovations, Inc.
Vienna University of Technology
Windmill Cardiovascular Systems, Inc.
Yale University

【レポートのキーワード】

人工心臓(VAD)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工心臓(VAD)の世界市場:医療機器パイプライン分析2016(Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2016)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆